Cargando…
Progress in the Research and Development of Anti-COVID-19 Drugs
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358523/ https://www.ncbi.nlm.nih.gov/pubmed/32733842 http://dx.doi.org/10.3389/fpubh.2020.00365 |
_version_ | 1783558858306748416 |
---|---|
author | Huang, Lianzhou Chen, Yuanqiu Xiao, Ji Luo, Weisheng Li, Feng Wang, Yuan Wang, Yiliang Wang, Yifei |
author_facet | Huang, Lianzhou Chen, Yuanqiu Xiao, Ji Luo, Weisheng Li, Feng Wang, Yuan Wang, Yiliang Wang, Yifei |
author_sort | Huang, Lianzhou |
collection | PubMed |
description | The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became an urgent work due to the lack of specific drugs for the treatment of COVID-19. Nevertheless, several existing drugs are available to relieve the clinical symptoms of COVID-19. We reviewed information on selected anti-SARS-CoV-2 candidate therapeutic agents published until June 2, 2020. We also discussed the strategies of the development of anti-COVID-19 drugs in the future. Our review provides a novel insight into the future development of a safer, efficient, and toxic-less anti-COVID-19 drug. |
format | Online Article Text |
id | pubmed-7358523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73585232020-07-29 Progress in the Research and Development of Anti-COVID-19 Drugs Huang, Lianzhou Chen, Yuanqiu Xiao, Ji Luo, Weisheng Li, Feng Wang, Yuan Wang, Yiliang Wang, Yifei Front Public Health Public Health The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became an urgent work due to the lack of specific drugs for the treatment of COVID-19. Nevertheless, several existing drugs are available to relieve the clinical symptoms of COVID-19. We reviewed information on selected anti-SARS-CoV-2 candidate therapeutic agents published until June 2, 2020. We also discussed the strategies of the development of anti-COVID-19 drugs in the future. Our review provides a novel insight into the future development of a safer, efficient, and toxic-less anti-COVID-19 drug. Frontiers Media S.A. 2020-07-07 /pmc/articles/PMC7358523/ /pubmed/32733842 http://dx.doi.org/10.3389/fpubh.2020.00365 Text en Copyright © 2020 Huang, Chen, Xiao, Luo, Li, Wang, Wang and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Huang, Lianzhou Chen, Yuanqiu Xiao, Ji Luo, Weisheng Li, Feng Wang, Yuan Wang, Yiliang Wang, Yifei Progress in the Research and Development of Anti-COVID-19 Drugs |
title | Progress in the Research and Development of Anti-COVID-19 Drugs |
title_full | Progress in the Research and Development of Anti-COVID-19 Drugs |
title_fullStr | Progress in the Research and Development of Anti-COVID-19 Drugs |
title_full_unstemmed | Progress in the Research and Development of Anti-COVID-19 Drugs |
title_short | Progress in the Research and Development of Anti-COVID-19 Drugs |
title_sort | progress in the research and development of anti-covid-19 drugs |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358523/ https://www.ncbi.nlm.nih.gov/pubmed/32733842 http://dx.doi.org/10.3389/fpubh.2020.00365 |
work_keys_str_mv | AT huanglianzhou progressintheresearchanddevelopmentofanticovid19drugs AT chenyuanqiu progressintheresearchanddevelopmentofanticovid19drugs AT xiaoji progressintheresearchanddevelopmentofanticovid19drugs AT luoweisheng progressintheresearchanddevelopmentofanticovid19drugs AT lifeng progressintheresearchanddevelopmentofanticovid19drugs AT wangyuan progressintheresearchanddevelopmentofanticovid19drugs AT wangyiliang progressintheresearchanddevelopmentofanticovid19drugs AT wangyifei progressintheresearchanddevelopmentofanticovid19drugs |